1. Home
  2. GNTA vs INLX Comparison

GNTA vs INLX Comparison

Compare GNTA & INLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNTA
  • INLX
  • Stock Information
  • Founded
  • GNTA 2014
  • INLX 1996
  • Country
  • GNTA Italy
  • INLX United States
  • Employees
  • GNTA N/A
  • INLX N/A
  • Industry
  • GNTA Biotechnology: Biological Products (No Diagnostic Substances)
  • INLX EDP Services
  • Sector
  • GNTA Health Care
  • INLX Technology
  • Exchange
  • GNTA Nasdaq
  • INLX Nasdaq
  • Market Cap
  • GNTA 70.8M
  • INLX 62.4M
  • IPO Year
  • GNTA 2021
  • INLX N/A
  • Fundamental
  • Price
  • GNTA $4.49
  • INLX $12.66
  • Analyst Decision
  • GNTA Strong Buy
  • INLX
  • Analyst Count
  • GNTA 1
  • INLX 0
  • Target Price
  • GNTA $25.00
  • INLX N/A
  • AVG Volume (30 Days)
  • GNTA 2.7K
  • INLX 4.6K
  • Earning Date
  • GNTA 01-01-0001
  • INLX 05-13-2025
  • Dividend Yield
  • GNTA N/A
  • INLX N/A
  • EPS Growth
  • GNTA N/A
  • INLX N/A
  • EPS
  • GNTA N/A
  • INLX N/A
  • Revenue
  • GNTA N/A
  • INLX $17,758,634.00
  • Revenue This Year
  • GNTA N/A
  • INLX $7.58
  • Revenue Next Year
  • GNTA N/A
  • INLX N/A
  • P/E Ratio
  • GNTA N/A
  • INLX N/A
  • Revenue Growth
  • GNTA N/A
  • INLX 3.21
  • 52 Week Low
  • GNTA $2.79
  • INLX $5.85
  • 52 Week High
  • GNTA $7.28
  • INLX $16.50
  • Technical
  • Relative Strength Index (RSI)
  • GNTA 59.43
  • INLX 46.00
  • Support Level
  • GNTA $4.25
  • INLX $12.09
  • Resistance Level
  • GNTA $5.98
  • INLX $13.41
  • Average True Range (ATR)
  • GNTA 0.25
  • INLX 0.68
  • MACD
  • GNTA 0.01
  • INLX -0.02
  • Stochastic Oscillator
  • GNTA 19.02
  • INLX 30.28

About GNTA Genenta Science S.p.A.

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.

About INLX Intellinetics Inc.

Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Document Management and Document Conversion. The Document Management segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Conversion offerings aid clients as a part of their overall document to convert documents from one medium to another. Majority of revenue is from Document Conversion Segment.

Share on Social Networks: